In addition, we also demonstrated that GCIP downregulated Id1 to render NSCLC cells more susceptibility to carboplatin and docetaxel, two commonly used anticancer drugs for NSCLC. This evidence concerns the gene CCNDBP1 and non-small cell lung carcinoma.